Physician, Dad, Professor of Medicine @UChicagoMed| Intensivist |Pulmonologist🫁|Geneticist🧬| Fighting #PulmonaryFibrosis |Opinions=mine only
Joined April 2017
- Tweets 1,512
- Following 474
- Followers 2,019
- Likes 9,134
372 Photos and videos
Pinned Tweet
17 Aug 2024
🔥🔥🔥Excited to share our latest review in AJRCCM delving into intricate genetic & epigenetic frameworks shaping #pulmonaryfibrosis & unraveling its complexities.
Grateful for collaboration with @JKropski @AnnaPodolanczuk @jskim8223, & all contributors.
atsjournals.org/doi/full/10.…
17 Aug 2024
5
29
7,048
Deji Adegunsoye, MD, PhD retweeted
May 31
The first snRNASeq & spatial transcriptomic analysis of bronchoscopic cryobiopsies from patients with Early IPF & preserved pulmonary functions is out on @biorxivpreprint and message is Early IPF is IPF‼️
biorxiv.org/content/10.64898…
3
24
69
9,894
Deji Adegunsoye, MD, PhD retweeted
Jan 28
Genetic heterogeneity in IPF has been a major gap. In our new paper, we define genetic endotypes of IPF, uncover subtype-specific risk, improve disease prediction, and identify telomere-associated polygenic risk as a key, previously unrecognized driver.
thelancet.com/journals/lanre…
1
3
5
230
Deji Adegunsoye, MD, PhD retweeted
1 Dec 2025
Finally in Print! The Official ATS Research Statement on Racial, Ethnic, Sex & Gender Equity for Inclusive Interstitial Lung Disease Research.
👏🏼 Drs Assayag, Adegonsoye, Cottin, Mageto, @ATSBlueEditor & the subcommittee members!!
#CurePF4All
atsjournals.org/doi/10.1164/…
1
5
21
2,044
Deji Adegunsoye, MD, PhD retweeted
4 Oct 2025
Overheard at #ECPPILD2025 today in Orlando: ""The prevalence of ILD is increasing and may be even higher than estimated because of failure to recognize the disease in clinical practice. We have the tools to better manage ILD, but recognition is key!" - @drdayjee Deji Adegunsoye, MD @PFWarrior @MartinezFerMD @joycecylee @scott_matson @AnnaPodolanczuk @OneVoiceILD @Pfforg #MedEd #MedTwitter #ILD
1
2
179
Deji Adegunsoye, MD, PhD retweeted
17 Sep 2025
Dr Ayodeji Adegunsoye – statement Co-Chair – gives a brief overview on the new Update of the International Multidisciplinary Classification of the Interstitial Pneumonias: An ERS/ATS Statement 📽️ 📖
Watch now on our ERS LinkedIn channel: bit.ly/3Vlt0o1
8
13
1,628
Deji Adegunsoye, MD, PhD retweeted
17 Aug 2025
Deji Adegunsoye, MD, MSc, PhD, FCCP (@drdayjee) brings expertise as Scientific Director of the ILD Program at @UChicagoMed to the 2025 Early Career Preceptorship Program on ILD!
Join him for insights on multidisciplinary approaches to optimizing patient care.
🔗 cmeo.me/EC-007
#ILD #Pulmonology #LungHealth #MedEd #PulmonaryCare
3
5
401
Deji Adegunsoye, MD, PhD retweeted
9 Jun 2025
Excited to share our study that is online @ThoraxBMJ examining clinical trajectories by ILD subtype and CT UIP pattern
thorax.bmj.com/content/early…
2
7
20
1,536
Deji Adegunsoye, MD, PhD retweeted
19 Jan 2025
Our newest paper: “Predicting lung aging using using single cell RNASeq data״ see thread below 👇🏼
journals.plos.org/ploscompbi…
21 Dec 2024
1/n
Just in time for the Holidays "Predicting lung aging using #scRNASeq data" is out!! #NormalLungAgingCellAtlas team report sa novel method that predicts lung age in smokers and non-smokers. Kudos lead authors, Drs Song, Bar-Joesph & team. See 🧵below
doi.org/10.1371/journal.pcbi…
6
25
3,737
Deji Adegunsoye, MD, PhD retweeted
17 Jan 2025
My book, An Intuitive Primer on Effective Functional Genomics Study Design, is published! I’d really appreciate it if you could help spread the word, and I’d love to hear your thoughts and feedback. It’s available on Amazon: tinyurl.com/mx2hewen
6
40
103
18,605
Deji Adegunsoye, MD, PhD retweeted
16 Nov 2024
Really cool! Our ‘Single-Cell Analysis Reveals Novel Immune Perturbations in Fibrotic Hypersensitivity Pneumonitis’ is on cover of the American Journal of Respiratory & Critical Care Medicine. Kudos to soon to be #DoubleDoc Amy Zhao & crew!!
#BestStudents
atsjournals.org/doi/full/10.…
8
41
4,097
9 Nov 2024
Truly honored to be the keynote speaker at this incredible event!
I loved every moment in Toronto, meeting such inspiring minds and learning about the amazing work you all are doing in pulmonary fibrosis.
Thank you for the warm welcome and the inspiration!🙏🏽🇨🇦
9 Nov 2024
@jolenehfisher, @twhcmr and I were honored to have @drdayjee at our @UofTRespirology #ILD educational day. He gave a fantastic talk on genetics of ILD and biomarkers: past, present and future. Thanks @drdayjee for coming along the way to Toronto to enhance our event! 🙏🙏🙏
1
17
1,033
Deji Adegunsoye, MD, PhD retweeted
22 Oct 2024
Belated ICLAF appreciation post - such a wonderful time with amazing people and great science in a beautiful location! Athens was amazing! #ICLAF2024
1
2
15
1,353
Deji Adegunsoye, MD, PhD retweeted
19 Oct 2024
Truth is - what I love most in Athens & in Greece - the people - their resilience, activism, energy and generosity 🥰
1
7
501
19 Oct 2024
Still basking in fun times & learnings from Athens🇬🇷 this week at #ICLAF2024:
• multiomics of pulmonary fibrosis 🫁
• novel pathophysiologic findings 🧬
• potential therapeutic targets 💊
• …and of course, insights into Greek mythology🏛️
#ScienceWin #MedTwitter #CurePF
2
2
41
1,833
19 Oct 2024
Athens: where medicine, democracy, philosophy, and the Olympics were born!
This ancient city isn’t just a historical wonder—it’s a feast for the eyes, overflowing with culture, charm, and jaw-dropping views.
1
1
20
819
19 Oct 2024
Day or night, the landscape dazzled with magnificent structures and breathtaking views—an awe-inspiring spectacle at every turn!
🏛️
#ICLAF2024
1
1
10
737
Deji Adegunsoye, MD, PhD retweeted
16 Oct 2024
Delighted to share our new study led by @AitanaAG90 evaluating the association of rare variants in telomere and non-telomere monogenic adult-onset Pulmonary Fibrosis genes and IPF patient survival where we also intersected their effects with #PRS of IPF. medrxiv.org/content/10.1101/…
2
7
11
950
15 Oct 2024
Dr. Marilyn Glassberg delivers an outstanding talk on sex differences in pulmonary fibrosis.
• need early disease models
• being female appears to be protective.
• Nitrogen mustard model is quite similar to Bleo
• Estrogen did not seem to stimulate fibrosis
#ICLAF2024
2
4
25
1,326
15 Oct 2024
Dr Bruno Crestani elegantly discusses endocrine fibroblast growth factors
• have paracrine functions /- exert antifibrotic/profibrotic effects
• FGF23 ⬆️ in fibrotic lung
• FGF19 analogs improved fibrosis in NASH, not ⬆️ in the lungs & ⬇️ in IPF plasma. #ICLAF2024
2
7
702
15 Oct 2024
Dr. David O’Dwyer deliver a fantastic talk on oral dysbiosis in IPF.
• Discusses lessons learned from the Clean-Up IPF trial.
The Streptococcus genus dominates the buccal microbiome
#ICLAF2024
1
1
11
702
15 Oct 2024
• No association between abundance of s. Mitis and mortality risk.
• progression of disease linked to loss of s. mitis over time.
@jskim8223
#ICLAF2024
1
2
285